HiFiBiO: High Fidelity Biology
Descrição
Fierce Biotech Names HiFiBiO Therapeutics a “Fierce 15” Biotech Company of 2023
HiFiBiO Therapeutics Single Cell and AI/ML Driven Clinical-Stage
HiFiBiO, Antibody Drug Discovery, Immune Modulation
Sophie FOULON, Scientific Officer
Andreas Raue on LinkedIn: HiFiBiO: High Fidelity Biology
HiFiBiO: High Fidelity Biology
HiFiBiO - High Fidelity Biology Management Team
Francisco ADRIAN, Vice President
Oliver MIKSE, Senior Scientist, Doctor of Philosophy
Mitochondrial variant enrichment from high-throughput single-cell
VYdesign Portfolio
HiFiBiO Therapeutics Single Cell and AI/ML Driven Clinical-Stage
HiFiBiO: High Fidelity Biology
de
por adulto (o preço varia de acordo com o tamanho do grupo)
